BR0113244A - Polimorfos de zaleplon; métodos e processos para a preparação dos mesmos; composição farmacêutica - Google Patents

Polimorfos de zaleplon; métodos e processos para a preparação dos mesmos; composição farmacêutica

Info

Publication number
BR0113244A
BR0113244A BR0113244-0A BR0113244A BR0113244A BR 0113244 A BR0113244 A BR 0113244A BR 0113244 A BR0113244 A BR 0113244A BR 0113244 A BR0113244 A BR 0113244A
Authority
BR
Brazil
Prior art keywords
zaleplon
methods
polymorphs
preparing
processes
Prior art date
Application number
BR0113244-0A
Other languages
English (en)
Inventor
Farhan Aslam
Brett Cowans
Stephen R Byrn
G Patrick Stahly
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0113244A publication Critical patent/BR0113244A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

"POLIMORFOS DE ZALEPLON; MéTODOS E PROCESSOS PARA A PREPARAçãO DOS MESMOS; COMPOSIçãO FARMACêUTICA". Esta invenção se relaciona com novas formas polimórficas cristalinas de zaleplon (N- [3- (3-cyanopyrazolo[1,5a]pirimidin-7-il)fenil]-N-etilacetamida), métodos para a preparação das mesmas, e seus usos como agentes ansiolíticos, anti-epilépticos, e sedativo-hipnóticos e relaxante de músculo do esqueleto.
BR0113244-0A 2000-08-03 2001-08-02 Polimorfos de zaleplon; métodos e processos para a preparação dos mesmos; composição farmacêutica BR0113244A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22278500P 2000-08-03 2000-08-03
PCT/US2001/024510 WO2002012244A2 (en) 2000-08-03 2001-08-02 Polymorphs of zaleplon and methods for the preparation thereof

Publications (1)

Publication Number Publication Date
BR0113244A true BR0113244A (pt) 2003-07-08

Family

ID=22833666

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113244-0A BR0113244A (pt) 2000-08-03 2001-08-02 Polimorfos de zaleplon; métodos e processos para a preparação dos mesmos; composição farmacêutica

Country Status (18)

Country Link
US (2) US20020072527A1 (pt)
EP (1) EP1305315A2 (pt)
JP (1) JP2004505979A (pt)
KR (2) KR20030036659A (pt)
CN (2) CN1847244A (pt)
AR (1) AR036324A1 (pt)
AU (2) AU2001283119B2 (pt)
BR (1) BR0113244A (pt)
CA (1) CA2417875C (pt)
HU (1) HUP0303055A3 (pt)
IL (1) IL154088A0 (pt)
MX (1) MXPA03001048A (pt)
NO (1) NO20030523L (pt)
NZ (1) NZ527455A (pt)
PL (1) PL365678A1 (pt)
SG (1) SG125971A1 (pt)
WO (1) WO2002012244A2 (pt)
ZA (1) ZA200300779B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032818A1 (en) * 2001-06-12 2005-02-10 Entire Interest N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon
CA2450384A1 (en) * 2001-06-12 2002-12-19 Biogal Gyogyszergyar Rt. Process for the production of zaleplon
CZ200471A3 (cs) * 2001-08-01 2004-11-10 Biogal Gyogyszergyar Rt Způsob purifikace N-[3-(3-kyanopyrazol[1,5-a]pyrimidin-7-yl)fenyl]-N-ethylacetamidu (zaleplon) a krystalické formy zaleplonu připravitelné tímto způsobem
CN101426504A (zh) * 2002-02-15 2009-05-06 特瓦药厂私人有限公司 包含规定粒径分布的扎来普隆的粉末组合物和由其制得的药物制品
AU2002343201A1 (en) * 2002-10-16 2004-05-04 Sanmar Speciality Chemicals Limited Synthesis of zaleplon
WO2005023813A1 (en) 2003-09-04 2005-03-17 Cipla Limited Zaleplon synthesis
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
WO2010065547A1 (en) * 2008-12-01 2010-06-10 Map Pharmaceuticals, Inc. Inhalation delivery methods and devices
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN102816163A (zh) * 2012-08-20 2012-12-12 四川禾邦阳光制药股份有限公司 扎来普隆的新晶型及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
KR0167261B1 (ko) * 1995-10-19 1999-04-15 문정환 전원공급 제어회로
US5714607A (en) * 1995-12-01 1998-02-03 American Cyanamid Company Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
AR029780A1 (es) * 2000-12-13 2003-07-16 Gador Sa Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida
CZ200471A3 (cs) * 2001-08-01 2004-11-10 Biogal Gyogyszergyar Rt Způsob purifikace N-[3-(3-kyanopyrazol[1,5-a]pyrimidin-7-yl)fenyl]-N-ethylacetamidu (zaleplon) a krystalické formy zaleplonu připravitelné tímto způsobem

Also Published As

Publication number Publication date
US20020072527A1 (en) 2002-06-13
IL154088A0 (en) 2003-07-31
CA2417875C (en) 2008-12-09
KR20030036659A (ko) 2003-05-09
NZ527455A (en) 2005-07-29
CN1847244A (zh) 2006-10-18
NO20030523L (no) 2003-03-11
NO20030523D0 (no) 2003-02-03
EP1305315A2 (en) 2003-05-02
US20050176735A1 (en) 2005-08-11
CN1610682A (zh) 2005-04-27
MXPA03001048A (es) 2004-02-26
WO2002012244A3 (en) 2002-06-13
WO2002012244A2 (en) 2002-02-14
PL365678A1 (en) 2005-01-10
AU2001283119B2 (en) 2007-11-15
KR20070086867A (ko) 2007-08-27
CA2417875A1 (en) 2002-02-14
JP2004505979A (ja) 2004-02-26
HUP0303055A3 (en) 2004-11-29
HUP0303055A2 (hu) 2004-01-28
SG125971A1 (en) 2006-10-30
AR036324A1 (es) 2004-09-01
AU8311901A (en) 2002-02-18
ZA200300779B (en) 2003-08-22

Similar Documents

Publication Publication Date Title
BR0113244A (pt) Polimorfos de zaleplon; métodos e processos para a preparação dos mesmos; composição farmacêutica
CA2523261A1 (en) Fused pyrimidine derivatives with crf activity
PE20020583A1 (es) Derivados de benzodiazepina como moduladores del receptor gaba a
TNSN06226A1 (en) Pyrazolo[1,5-a]pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases
PE20020406A1 (es) 7-OXO-PIRIDO[2,3-d]PIRIMIDINAS 2,6-DISUSTITUIDAS COMO INHIBIDORES DE LAS PROTEINAS CINASAS
TW200745121A (en) Chemical compound
EA200800992A1 (ru) 2-амино-7,8-дигидро-6н-пиридо[4,3-d]пиримидин-5-оны, способ их получения, способ терапии с их помощью, компонент композиции и композиция на их основе, 2,4-диоксопиперидиновые соединения для их получения
NO20055510L (no) 2-alkynyl- og 2-alkenylpyrazolo [4,3-E]-1,2,4-triazolo-[1,5-C]-pyrimidin-adenosin A2A-reseptorantagonister
ATE402707T1 (de) Imidazoä1,5aütriazoloä1,5dübenzodiazepin- derivative zur behandlung kognitiver störungen
NO307181B1 (no) Fremgangsmåte for fremstilling av N-[3(3-cyanopyrazol[1,5- a]pyrimidin-7-yl)fenyl]-N-etylacetamid
HUP0303254A2 (hu) Új pirimidinvegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
NO20052172D0 (no) 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter
PL374176A1 (en) Process for purifying n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process
ATE401332T1 (de) Neue polymorphe von olanzapin-hydrochlorid
PE20050995A1 (es) Derivados oxazol de tetraciclinas
PL372942A1 (en) Process for the production of n-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon)
EA200200320A1 (ru) ПОЛИМОРФЫ N-МЕТИЛ-N-(3-{3-[2-ТИЕНИЛКАРБОНИЛ]ПИРАЗОЛ[1,5-α]ПИРИМИДИН-7-ИЛ}ФЕНИЛ)АЦЕТАМИДА И ОТНОСЯЩИЕСЯ К НИМ КОМПОЗИЦИИ И СПОСОБЫ
BR9911357A (pt) Combinações terapêuticas de moduladores (seletivos) de receptor de estrogênio (serm) e secretagogos de hormÈnio de crescimento (ghs) para tratar fragilidade músculo-esqueletal
FI875501A (fi) 6,7-dihydro-/1,2,4/triazolo/1,5-a// 1,3,5/triazin-2-sulfonsyraamider, foerfarande foer deras framstaellning och deras anvaendning som medel med herbicid och vaextreglerande verkan.
BR0214068A (pt) Preparação de derivados 3,3a,8,12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b] furano transfundidos
WO2008068600A3 (en) An improved process for the preparation of zaleplo
WO2006070244A3 (en) A process for the preparation of zaleplon
AR032519A1 (es) Compuestos
AR032520A1 (es) Compuestos
HUP0400325A3 (en) Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.